When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progression

Blood Adv. 2019 Jan 22;3(2):212-215. doi: 10.1182/bloodadvances.2018021253.

Authors

Giovanni Palladini¹, Giampaolo Merlini¹

Affiliation

¹ Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Abstract

This article has a companion Counterpoint by Sanchorawala.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Disease Progression
Humans
Immunoglobulin Light-chain Amyloidosis / diagnosis*
Immunoglobulin Light-chain Amyloidosis / therapy*
Recurrence
Time-to-Treatment
Treatment Outcome